Could an asthma drug tame this brutal blistering disease?
NCT ID NCT04206553
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether dupilumab, a drug already used for asthma and eczema, can help people with bullous pemphigoid, a painful blistering skin condition. 106 adults received either dupilumab or a placebo, plus standard steroid treatment. The main goal was to see if more people could achieve long-term remission without needing steroids.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
dupilumab (Dupixent)
What this could lead to
If successful, dupilumab could offer a new treatment option for bullous pemphigoid, potentially reducing the need for long-term steroids.
What could go wrong
This is a mid-stage trial with only 106 participants. Results may not apply to all patients, and side effects or lack of effectiveness are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BULLOUS PEMPHIGOID are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Regeneron Study Site
Scottsdale, Arizona, 85259, United States
-
Regeneron Study Site
Redwood City, California, 94063, United States
-
Regeneron Study Site
Farmington, Connecticut, 06030, United States
-
Regeneron Study Site
Miami, Florida, 33125, United States
-
Regeneron Study Site
Iowa City, Iowa, 52242, United States
-
Regeneron Study Site
Boston, Massachusetts, 02116, United States
-
Regeneron Study Site
Chapel Hill, North Carolina, 27516, United States
-
Regeneron Study Site
Portland, Oregon, 97239, United States
-
Regeneron Study Site
Philadelphia, Pennsylvania, 19104, United States
-
Regeneron Study Site
Murray, Utah, 84107, United States
-
Regeneron Study Site
Kogarah, New South Wales, 2217, Australia
-
Regeneron Study Site
Box Hill, Victoria, 3128, Australia
-
Regeneron Study Site
Bobigny, 93009, France
-
Regeneron Study Site
Bordeaux, 33000, France
-
Regeneron Study Site
Lille, 59037, France
-
Regeneron Study Site
Nice, 06200, France
-
Regeneron Study Site
Paris, 75010, France
-
Regeneron Study Site
Rouen, 76031, France
-
Regeneron Study Site
Münster, North Rhine-Westphal, 48149, Germany
-
Regeneron Study Site
Mainz, Rhineland-Palatinate, 55131, Germany
-
Regeneron Study Site
Lübeck, Schleswig-Holstein, 23538, Germany
-
Regeneron Study Site
Berlin, 10117, Germany
-
Regeneron Study Site
Buxtehude, 21614, Germany
-
Regeneron Study Site
Erlangen, 91054, Germany
-
Regeneron Study Site
Freiburg im Breisgau, 79104, Germany
-
Regeneron Study Site
Munich, 80802, Germany
-
Regeneron Study Site
Stuttgart, 70178, Germany
-
Regeneron Study Site
Hirosaki, 036-8563, Japan
-
Regeneron Study Site
Ichinomiya, 491-8558, Japan
-
Regeneron Study Site
Osaka, 545-8586, Japan
-
Regeneron Study Site
Sapporo, 060-8648, Japan
-
Regeneron Study Site
Tokyo, 160-8582, Japan
-
Regeneron Study Site
Krakow, Lesser Poland Voivodeship, 31-147, Poland
-
Regeneron Study Site
Badalona, Barcelona, 08916, Spain
-
Regeneron Study Site
Madrid, 28034, Spain
-
Regeneron Study Site 2
Dresden, Saxony, 01307, Germany
-
Regeneron Study site
Marburg, 35043, Germany
-
Regeneron Study site
Kurume, Hukuoka, 830-0011, Japan
-
Regeneron Study site'
Magdeburg, 39120, Germany
-
Regeneron Study site'
Ossy, 42-624, Poland
-
Regeneron Study site'
Wroclaw, 50566, Poland
-
Regeneron study Site
Birmingham, Alabama, 35233, United States
-
Regeneron study Site
Orlando, Florida, 32827, United States
-
Regeneron study Site
Ann Arbor, Michigan, 48109-5314, United States
-
Regeneron study Site
Providence, Rhode Island, 02908, United States
-
Regeneron study Site
Charlottesville, Virginia, 22903, United States
-
Regeneron study Site
Afula, 1834111, Israel
-
Regeneron study Site
Petah Tikva, 49100, Israel
-
Regeneron study Site
Tel Aviv, 6423906, Israel
-
Regeneron study Site
Madrid, 28046, Spain
-
Regeneron study Site
Pamplona, 31008, Spain
-
Regeneron study Site
Taipei, Zhongzheng District, 10002, Taiwan
-
Regeneron study Site
Taoyuan City, 33305, Taiwan